Transdermal uptake and organ distribution of silver from two different wound dressings in rats after a burn trauma

Wound Repair and Regeneration

Volumn 22, Issue 5, 2014, Pages 654-659

  Pfurtscheller, Klaus ^a   Petnehazy, Thomas ^a   Goessler, Walter ^b   Bubalo, Vladimir ^a   Kamolz, Lars Peter ^a   Trop, Marija ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN; CARDIAC MUSCLE; CONTROLLED STUDY; FECES ANALYSIS; FECES LEVEL; HEART; LUNG; MALE; MASS SPECTROMETRY; METAL FECES LEVEL; NONHUMAN; ORGAN DISTRIBUTION; PARENCHYMA; PRIORITY JOURNAL; RAT; SCALD; SILVER DRESSING; TESTIS; TISSUES; TRACE METAL BLOOD LEVEL; WOUND DRESSING;

EID: 85007198121     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12209     Document Type: Article

References (27)

1. Klasen HJ. Historical review of the use of silver in the treatment of burns. I. early uses. Burns 2000; 26: 117–130.
2. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. renewed interest for silver. Burns 2000; 26: 131–138.
3. Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine 2006; 1: 441–449.
4. Lansdown AB. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci 2010; 2010: 910686.
5. Lansdown AB. Silver. I: its antibacterial properties and mechanism of action. J Wound Care 2002; 11: 125–130.
6. Walker M, Parsons D. The biological fate of silver ions following the use of silver-containing wound care products—a review. Int Wound J 2012 Nov 22 [Epub ahead of print].
7. Lansdown AB, Williams A, Chandler S, Benfield S. Silver absorption and antibacterial efficacy of silver dressings. J Wound Care 2005; 14: 155–160.
8. Lansdown AB. Silver. 2: toxicity in mammals and how its products aid wound repair. J Wound Care 2002; 11: 173–177.
9. Lansdown AB. Critical observations on the neurotoxicity of silver. Crit Rev Toxicol 2007; 37: 237–250.
10. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, et al. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 2007; 15: 94–104.
11. Nadworny PL, Landry BK, Wang J, Tredget EE, Burrell RE. Does nanocrystalline silver have a transferable effect? Wound Repair Regen 2010; 18: 254–265.
12. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 2011; 7: 347–354.
13. You C, Han C, Wang X, Zheng Y, Li Q, Hu X, et al. The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep 2012; 39: 9193–9201.
14. Pfurtscheller K, Petnehazy T, Goessler W, Wiederstein-Grasser I, Bubalo V, Trop M. Innovative scald burn model and long-term dressing protector for studies in rats. J Trauma Acute Care Surg 2013; 74: 932–935.
15. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006; 60: 648–652.
16. Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns 2007; 33: 979–985.
17. Moiemen NS, Shale E, Drysdale KJ, Smith G, Wilson YT, Papini R. Acticoat dressings and major burns: systemic silver absorption. Burns 2011; 37: 27–35.
18. Wang X, Kempf MBM, Mott JBS, Chang HBS, Francis RC, Liu PMP, et al. Silver absorption on burns after the application of acticoat (TM): data from pediatric patients and a porcine burn model. J Burn Care Res 2009; 30: 341–348.
19. Wan AT, Conyers RA, Coombs CJ, Masterton JP. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 1991; 37: 1683–1687.
20. Maitre S, Jaber K, Perrot JL, Guy C, Cambazard F. Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine. Ann Dermatol Venereol 2002; 129: 217–219.
21. Brandt O, Mildner M, Egger AE, Groessl M, Rix U, Posch M, et al. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomedicine 2012; 8: 478–488.
22. van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012; 6: 7427–7442.
23. Tang J, Xiong L, Wang S, Wang J, Liu L, Li J, et al. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 2009; 9: 4924–4932.
24. Iwasaki S, Yoshimura A, Ideura T, Koshikawa S, Sudo M. Elimination study of silver in a hemodialyzed burn patient treated with silver sulfadiazine cream. Am J Kidney Dis 1997; 30: 287–290.
25. Rigo C, Roman M, Munivrana I, Vindigni V, Azzena B, Barbante C, et al. Characterization and evaluation of silver release from four different dressings used in burns care. Burns 2012; 38: 1131–1142.
26. Selig HF, Lumenta DB, Giretzlehner M, Jeschke MG, Upton D, Kamolz LP. The properties of an “ideal” burn wound dressing—what do we need in daily clinical practice? results of a worldwide online survey among burn care specialists. Burns 2012; 38: 960–966.
27. Wang XQ, Chang HE, Francis R, Olszowy H, Liu PY, Kempf M, et al. Silver deposits in cutaneous burn scar tissue is a common phenomenon following application of a silver dressing. J Cutan Pathol 2009; 36: 788–792.